 Wells Fargo Company MN lessened its holdings in Dicerna Pharmaceuticals Inc NASDAQ:DRNA by 55.7 during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 58,020 shares of the biopharmaceutical companys stock after selling 73,061 shares during the quarter. Wells Fargo ... 